Revolution Medicines · 9 hours ago
Senior Oncology Account Manager – Dallas West, TX
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The Senior Oncology Account Manager is responsible for the direct promotion of Revolution Medicines’ products and for building strong professional relationships with key customers and stakeholders involved in the care of cancer patients.
Health CareLife ScienceMedical
Responsibilities
Effectively markets Revolution Medicines’ product portfolio in the designated territory
Responsible for exceeding assigned performance goals for the territory by effectively positioning the benefits and use of RevMed’s products for appropriate patients
Exhibits effective time management by directing efforts towards engagements that drive brand value and prioritizing activities that positively impact patients
Partners with key internal stakeholders to remove barriers to care, ensuring every eligible patient receives timely access to RevMed products
Demonstrates the ability to flex between virtual and in-person engagements and develop business plan considering account communication preferences
Ability to analyze key market data points and action insights into effective business planning and implements these plans by engaging key targets via call optimization and resource utilization
Develops deep, sustained customer relationships across assigned accounts and proactively challenges customers through innovative, value-driven solutions
Represent RevMed’s brands in a professional, compliant, ethical, and effective manner
Exhibits a thorough understanding of disease states, Revolution Medicine’s products, and relevant competitor offerings and effectively articulates value across all communication channels (i.e. digital, live, etc.)
Possess comprehensive understanding of the reimbursement process and fulfillment pathways for oral oncolytics
Demonstrates highly effective territory management and superior selling competencies
Illustrates the ability to creatively gain 'access' to customers in the modern landscape
Drives team effectiveness and accomplishment of shared goals by leveraging and sharing expertise and information
Effective management of territory resources and budget
Complies with all laws, regulations and policies that govern the conduct of Revolution Medicines staff
Visibly embodies corporate Core Values while cultivating an energized team culture focused on patient impact
Qualification
Required
MA/MS/BA/BS degree and 20 years of biopharma industry experience
15+ years prior experience in oncology product sales
Proven track record of product launch success in the oncology therapeutic space
Oral Oncolytic product launch experience
Experience launching oncology products with companion diagnostics
Proven performer in highly competitive marketplaces
Proven performer in solo-representative selling environments
Demonstrated success operating in small/midsize biotechnology environments
Ability to meet territorial travel requirements
Ability to travel to meetings/training/programs, as necessary
Proven effectiveness in highly collaborative & cross-functional working environments
Valid driver's license
Must permanently reside in the territory for which they are accountable
~50% travel required
Preferred
Experience in the GI and/or NSCLC oncology space
Advanced degree (MBA, PharmD, PhD)
Strong organization, planning, project management, technical and analytical skills
Other relevant experience (e.g., sales operations, market research, market access, etc.)
Ability to work independently to execute strategic and tactical plans under tight timelines
Delivers compelling presentations to individuals and groups, adapting messaging to maximize audience engagement
Highly proficient in Microsoft suite including Powerpoint, Excel, Word
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Recent News
Company data provided by crunchbase